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ABSTRACT
In this work, a new method was developed for the determination of two phenothiazine drugs, namely thioridazine hydrochloride and
chlorpromazine hydrochloride using gold nanoparticles-based resonance light scattering (RLS) technique. The addition of these drugs
to gold nanoparticles solution in acidic medium leads to the aggregation of nanoparticles, which, in turn, causes a marked enhancement
in RLS intensity at 400 nm. The aggregates were characterized by UV-Vis spectroscopy and transmission electron microscopy. The
effects of important experimental factors such as pH, concentration of gold nanoparticles and incubation time on RLS signal were investigated and optimized. Under the optimum conditions, the calibration graphs were linear in the range of 3.6 - 36 and 3.5 - 30 ng/mL, for
thioridazine hydrochloride and chlorpromazine hydrochloride, respectively with corresponding limits of detection of 1.1 and 1.0 ng/mL.
The results indicate that the nanogold-based RLS is a very sensitive and simple method for the determination of phenothiazine drugs in
pharmaceutical samples and human plasma.
Key words: Gold nanoparticles, Resonance light scattering, Phenothiazine drugs, Thioridazine hydrochloride, Chlorpromazine
hydrochloride

INTRODUCTION
Gold nanoparticles (GNPs) have many interesting
physicochemical characteristics, which have led to their wide
applications in various areas of chemistry(1-3). One of the
well-established properties of GNPs is their analyte-mediated aggregation in solution, which has been widely utilized
for chemical sensing of various organic and inorganic
substances(4-8). Most of the aggregation-based procedures
use the red-shift in surface plasmon band of GNPs or change
in its extinction intensity for optical detection. However, a
much more useful and sensitive property of GNPs, which can
be used for sensing purposes, is their ability to efficiently
scatter light(9).
Resonance light scattering (RLS) spectroscopy, introduced by Pasternak and coworkers(10) in 1993, is a simple and
sensitive analytical tool, which has been extensively used
for various (bio)analytical tasks(11,12). Since RLS intensity
depends on the molar absorptivity as well as the size of the
scatterer, it is particularly useful in studying the aggregation
of chromophores in various chemical and biological systems.
* Author for correspondence. Tel: +984113393109;
E-mail: amjadi@tabrizu.ac.ir

The RLS property of GNPs has recently received much attention and has been applied to the detection and quantification
of some biological and pharmaceutical compounds(13-23).
Thioridazine hydrochloride, 10-[2-(l-Methyl-2-piperidyl)ethyl]-2-methylthiophenothiazine hydrochloride (TZH,
Figure 1A) and chlorpromazine hydrochloride, 10-[2-chloro10-(3-dimethylaminopropyl]-phenothiazine
monohydrochloride (CPH, Figure 1B) are phenothiazine antipsychotic
drugs, which act on both positive and negative symptoms
of schizophrenia. They are often used in combination with
antidepressants in the therapy of many psychiatric disorders,
such as psychotic depression in the course of schizophrenia
and schizoaffective psychosis(24). Several methods have been
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Figure 1. Chemical structures of (A) thioridazine hydrochloride and
(B) chlorpromazine hydrochloride.
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reported for the determination of TZH and CPH in pharmaceutical preparations and biological samples. Among them
spectrophotometry(25), voltammetry(26,27), chemiluminescence method(28,29), fluorimetry(30), chromatography(31-35)
and capillary electrophoresis(36) have been mentioned as
recently proposed methods. However, it is important to
develop simple and sensitive methods for quality assurance
of TZH and CPH in pharmaceutical industries. To the best
of our knowledge, RLS has not been applied to the determination of these drugs. We here proposed a simple and
sensitive RLS-based method, using GNPs as probe, for
the determination of TZH and CPH. The addition of these
compounds to GNPs solution leads to a red-shift in the
plasmon band and a weak enhancement of the absorption
intensity and also causes a significant enhancement of RLS
signal. Based on the obtained results, a highly sensitive,
simple and fast method was developed for the determination of TZH and CPH. Compared to the previously reported
methods such as spectrophotometry(25), voltammetry(26,27),
chemiluminescence(29) and fluorimetry(30), the proposed
method has lower limit of detection and higher sensitivity.
Also compared to chromatographic methods, our method is
simpler and less time-consuming.

MATERIALS AND METHODS
I. Apparatus
A Shimadzu RF-540 spectrofluorimeter (Kyoto, Japan)
was used for recording and measuring the RLS spectra. A
Cary-100 Varian UV-Visible spectrophotometer (Australia)
was used for recording the absorption spectra. A Zeiss EM
900 (Germany) transmission electron microscope (TEM)
was used for obtaining TEM images. pH measurements were
carried out by using a Metrohm 827 pH meter.
II. Reagents
All reagents used were of analytical reagent grade.
Double distilled deionized water (obtained from Ghazi
Serum Co.) was used throughout. HAuCl4·2H2O and sodium
citrate were purchased from Merck (Darmstadt, Germany)
and 1% (w/v) solutions of them were prepared in water. Thioridazine hydrochloride (TZH, 99%) and chlorpromazine
hydrochloride (CPH, 99.5%) were kindly provided by Minoo
Pharmaceutical, Cosmetic & Hygienic Co. (Tehran, Iran) and
Tehran Chemie Pharmaceutical (Tehran, Iran), respectively.
Their stock standard solutions (1000 μg/mL) were prepared
by dissolving the appropriate amount of sample powder
in water. These solutions are stable for at least one month
when protected from light and stored at 4°C. Working standard solutions were prepared daily by appropriate dilution
of stock solutions. Britton-Robinson buffer solutions (BR,
pH 2 - 6) were prepared by mixing appropriate volumes of
0.2 M sodium hydroxide solution and 0.04 M of boric acid,
0.04 M phosphoric acid and 0.04 M acetic acid solutions.

III. Preparation of Gold Nanoparticles
GNPs were prepared by sodium citrate reduction
method(17). To a 150-mL beaker, 1.0 mL of 1% HAuCl4 and
about 100 mL of water were added and the solution was
heated up to 95°C. 5.0 mL of 1% sodium citrate solution was
added drop by drop while the solution is vigorously stirred.
The solution was kept at 95°C for 4 - 5 min. When the color
of solution changed to bright red, the solution was allowed
to cool to room temperature and transferred into a 100 mL
volumetric flask, diluted to the mark with water and mixed
completely. The average size of the prepared GNPs is about
13 nm, which is estimated from TEM image and UV-Vis
spectrum(37). The particle concentration of the GNPs was
estimated to be 8.3 nM according to Beer’s law using an
extinction coefficient of ca. 108 L/mol/cm at 520 nm(38).
IV. General Procedure
Into a 10 mL volumetric flask, appropriate amounts
of TZH or CPH, 1.0 mL GNPs and 0.5 mL BR buffer solution (pH 4.0 for TZH and pH 3.0 for CPH) were added in
turn. After addition of each reagent, the resulting solution
was mixed. The mixture was finally diluted to the mark with
water. After shaking then waiting for 20 minutes, the RLS
spectra were recorded by synchronous scanning at λex = λem
(i.e. Δλ = 0 nm). The RLS intensity of the reaction product
(I) and of the reagent blank (I0) were measured at 400 nm
and the measurement parameter was calculated as ΔI = I - I0.
V. Procedure for Pharmaceutical Preparation
Twenty tablets of thioridazine hydrochloride (Minoo,
Iran) or chlorpromazine hydrochloride (Tehran Chemie Pharmaceutical, Iran) were weighed in order to find the average
mass of each tablet. The contents were then powdered and
mixed. 10 mg of this powder was accurately weighed and
dissolved in about 10 mL water, filtered into a 25 mL volumetric flask and diluted to the mark with water. A suitable
aliquot of this solution was taken for the determination of
TZH or CPH according to the recommended procedure. The
recovery assays were carried out using the same procedure
but adding the known amounts of pure drug.
VI. Procedure for Plasma Samples
An aliquot of 0.5 mL human plasma spiked with various
amount of TZH or CPH was transferred to a centrifuge tube
and 1.0 mL of 5% HNO3 (Merck) was added to precipitate
proteins. The tube was then centrifuged for 20 min at 730 ×g
and the clear supernatant solution was transferred to a 10 mL
volumetric flask and diluted to the mark with water. A suitable aliquot of this solution was used for the determination of
TZH or CPH according to IV. General Procedure and using
the standard addition technique. The corresponding blank
was also prepared by the same procedure and using drugfree plasma.
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Figure 2. The transmission electron microscope (TEM) images for (A) gold nanoparticles, (B) TZH-gold nanoparticles.

RESULTS AND DISCUSSION

UV-visible spectrum of GNPs solution exhibits a wellknown absorption maximum at 520 nm as a result of localized surface plasmon resonance(4). Upon addition of trace
TZH or CPH, the color of GNPs solution gradually changes
from red to blue and accordingly the absorption band shifted
to longer wavelengths. A new absorption peak appears at
about 655 nm when TZH is mixed with GNPs (in the case of
CPH, the new peak located around 640 nm). This band can
be attributed in part to the coupling between the plasmons
of particles that are in close contact in the formed aggregates, and in part to the longitudinal electronic oscillation
along the chain of linked spherical nanoparticles(7,39). This is
supported by TEM image shown in Figure 2. TEM image for
GNPs solution before addition of phenothiazine (Figure 2A)
indicates that prepared GNPs are homogenous and almost
spherically-shaped. The average diameters of GNPs were
estimated to be about 13 nm, which is also consistent with
the size calculated with the equation proposed by Haiss et
al.(37) using UV-V is spectrum. When drugs were added into
the solution of GNPs, the mean diameters of the particles
increased due to the aggregate formation. Moreover, as seen
from Figure 2B, the interparticle distances in these aggregates decrease to less than the average particle diameter and
chain-like or string-like structures are formed. This gives an
anisotropic character to binding products in contrast to the
largely isotropic character for GNPs.
RLS spectra of gold nanoparticles-TZH system are
shown in Figure 3. It can be seen that GNPs have certain
RLS intensity when they exist alone; however, when they
interact with TZH to form the new binding products, the
RLS intensity of the solution is greatly enhanced and a new
RLS spectrum appeared. The maximum RLS wavelength is
located at 400 nm; in addition, there are two smaller peaks

RLS Intesity (arbitrary units)

I. Absorption and Scattering Spectra of Gold NanoparticlesCPH System
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Figure 3. RLS spectra of (1) gold nanoparticles; (2 - 6) gold nanoparticles-TZH system; [TZH]: (2) 10 ng/mL; (3) 15 ng/mL; (4) 24 ng/mL;
(5) 30 ng/mL; (6) 36 ng/mL. pH = 4.0, Concentration of GNPs is
8.3 × 10 -10 M.

at 470 and 535 nm. Moreover, as seen from Figure 3, with
the increase of TZH concentration, the RLS intensities are
enhanced proportionately. Similar results (not shown) were
also obtained for GNPs-CPH system.
According to the resonance light scattering theory(11),
the RLS effect is observed when the wavelength of the
incident radiation is close to an absorption band of the scatterer. The comparison between the scattering (Figure 4) and
absorption spectra shows that the scattering is located near
the molecular absorption band of the system. Therefore, the
observed elastic scattering can be considered as a resonance
light scattering. The RLS enhancement may be rationalized
as follows: citrate-stabilized GNPs have negatively charged
surfaces, which result from adsorption of citrate anions
onto the nanogold surfaces. In our experimental pH values,
citrate ions exist mainly as ‑ OOC-CH2-C(OH)(COOH)CH2-COOH (H3L-) and little - OOC-CH2-C(OH)(COOH)CH2-COO- (H2L2-) species. Therefore, we can consider
the GNPs as [(Au)n(H2L)m(H3L)p]x- assemblies. Under the
reaction condition, TZH or CPH molecules exists in the form
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of positively charged ions, A+ (pKa = 9.5 and 9.3 for TZH
and CPH, respectively(40)), which, by virtue of electrostatic
attraction can bind with –COO- moieties of citrate ions to
form complex [(Au)n(H2L)m(H3L)p]x- (A+)Y. Furthermore,
the drugs can combine with the GNPs through Au-S covalent bond. Anyway, combining TZH or CPH molecules with
GNPs leads to the neutralization of the majority charges of
nanoparticles, which resulted in aggregation and also in the
size increase of the scatterers. The overall result of these
phenomena is the enhancement of RLS signal(15). In addition, introducing TZH or CPH to GNPs solution might alter
dielectric constant of the surrounding medium of the nanogolds as indicated by the red shift and broadening of plasmon
absorption. The change in dielectric constant affects scattering cross-section of particles, which finally leads to RLS
enhancement(22).
II. Optimization of Experimental Conditions
The effect of important variables (pH, kind of buffer,
the amount of GNPs and incubation time) on the measurement parameter was studied by one-at-a-time method.
The pH of the solution plays an important role in the
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Figure 4. Effect of the pH on RLSpH
signals; GNPs concentration =
8.3 × 10 -10 mol/L, [TZH] = 30 ng/mL and [CPH] = 30 ng/mL.

interaction between GNPs and studied drug. Thus the influence of solution pH on RLS signals was studied over the pH
range of 2.0 - 6.0. The results are shown in Figure 4. It can be
seen that the optimum pH ranges are 3.5 - 4.5 and 3.0 - 3.5 for
TZH and CPH, respectively. At higher or lower pH a marked
decrease in the ΔI values is observed. Therefore, pH 4.0
and pH 3.0 were selected for TZH and CPH determinations,
respectively. Among three buffer solutions tested (i.e. HClNaAc, HAc-NaAc and BR buffer solutions), BR buffer gave
the best results in terms of sensitivity and linear range for
both drugs. It should be noted that RLS intensity of GNPs
themselves does not change considerably with pH.
The effect of concentration of GNPs solution on RLS
intensity was also investigated. The results showed that the
range of linearity is wider for the higher concentration of
GNPs solution at the expense of sensitivity. With the decrease
of GNPs concentration the sensitivity increases but the linear
range is narrowed because GNPs solution has aggregated so
sharply that sedimentation takes place quickly. Sensitivities
(slopes of the calibration graphs), linear range, and correlation coefficient (r) for three amounts of GNPs, are listed in
Table 1. The optimization curves for GNPs concentration
are shown in Figure 5. It can be seen that the ΔI for both
drugs reaches the highest value when GNPs concentration
is 8.3 × 10 -10 M. If the concentration of GNPs is higher or
lower than this value, ΔI will decrease. When the concentration of GNPs is too low, the concentration of the binding
products is less, which makes the RLS intensity lower; on the
contrary, excessive GNPs will bind with TZH or CPH cations
competitively, so the number of the binding drug for every
GNP will reduce, which results in decreasing the intensity
of RLS. Therefore the concentration of 8.3 × 10 -10 M (corresponding to 1.0 mL of prepared nanogold solution in 10 mL
total volume) is chosen as optimum for subsequent works.
Finally, the influence of incubation time on RLS intensity was studied. According to the obtained results, for both
drugs the RLS intensity is enhanced rapidly following the
addition of the drugs and reaches a plateau in about 20 min.
The signal remains stable for at least 60 min. The RLS intensity of blank solution (GNPs in corresponding buffer) is also
enhanced about 8% during the first 15 min and then remains
nearly constant for longer time.

Table 1. Analytical parameters for the determination of phenothiazine drugs with different amounts of GNPs (λ ex = λem= 400 nm)
Concentration of gold
nanoparticles (M × 10-10)

Linear range
(ng/mL)

Sensitivity (Slope of the
calibration graph)

Correlation
coefficient (r)

LOD
(ng/mL)

LOQ
(ng/mL)

Thioridazine HCl
8.3

3.6 - 36

0.49 ± 0.01

0.9984

1.1

3.6

16.6

4.3 - 54

0.41 ± 0.004

0.9994

1.3

4.3

24.9

5.6 - 84

0.32 ± 0.007

0.9984

1.7

5.6

Chlorpromazine HCl
8.3

3.5 - 30

0.37 ± 0.005

0.9994

1.0

3.5

16.6

3.8 - 54

0.23 ± 0.005

0.9979

1.2

3.8

24.9

6.1 - 96

0.16 ± 0.007

0.9929

1.8

6.1
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of the interfering substance. The obtained results are listed
in Tables 2. As can be seen, the selectivity of the method is
satisfactory and it can be used to determine these drugs in
pharmaceutical formulations.

16
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IV. Analytical Applications

∆I

I 88

44

00

00

5
5

10
10

15
15

20
20

25
25

Concentration of GNPs (× 10 -10 M)

Concentration of G NPs (× 10-10 M)
Figure 5. Effect of concentration of GNPs on RLS signal; [TZH] =
30 ng/mL, [CPH] = 30 ng/mL and pH = 4.0 (for TZH) and 3.0 (for
CPH).

III. Analytical Figures of Merit
By using the optimum conditions described above,
RLS-based methods were developed for the determination of
TZH and CPH. In order to obtain the calibration graphs, the
enhanced RLS intensities (ΔI) of series of standard solutions
of drugs were measured by following general procedure. As
stated above, the linearity increased with amount of nanogold while the sensitivity decreased. Analytical parameters
such as linear ranges, correlation coefficients (r), and limits
of detection are listed in Table 1. The limits of detection
(LOD) and quantification (LOQ) were calculated as 3sb/m
and 10sb/m where sb is standard deviation of blank signal and
m is slope of the calibration graph(41,42). Here LOD is defined
as analyte concentration giving a signal equal to blank signal
plus three standard deviations of the blank. In such a case
the probability of Type I and Type II errors would be about
7%. Similarly, LOQ which is regarded as the lower limit
for precise quantitative measurements is usually defined as
analyte concentration giving a signal equal to blank signal
plus ten standard deviations of the blank.
In order to study the precision of the method, a series
of five standard solutions of 15 ng/mL TZH or CPH were
measured in the same day. The relative standard deviations
(RSDs) were found to be 1.2 and 1.3% for TZH and CPH,
respectively.
In order to study the selectivity of the proposed method,
the effects of some foreign substances such as common
inorganic ions and some saccharides and amino acids on the
determination of TZH and CPH were examined. A substance
was considered to interfere when the variation in RLS signal
was more than ± 5%. Maximum interferent-to-analyte mass
ratio tested for all interfering substances was 2000. When a
substance at this mass ratio caused more than ± 5% variation in analyte signal the lower ratios were tested until the
variation in signal became less than or equal to ± 5%. The
corresponding ratio was considered as the tolerance limit

TZH and CPH were satisfactorily determined in pharmaceutical products commercialized in Iran (thioridazine
hydrochloride and chlorpromazine hydrochloride tablets
with nominal contents of 10 and 25 mg, respectively and
chlorpromazine hydrochloride injections with a nominal
content of 25 mg/mL) by the proposed method. The obtained
results are summarized in Table 3. Statistical analysis of the
assay results showed satisfactory precision of the proposed
method with no significant difference between certified and
experimental results.
Recovery experiments on pharmaceutical preparations
spiked with different amounts of drugs were also carried out.
The obtained results are summarized in Table 4, indicating
satisfactory recoveries (between 96 and 105%).
The method was also applied to the determination of
the drugs in spiked human plasma. The results are given in
Table 4, indicating that the proposed method has sufficient
precision and accuracy for the determination of TZH and
CPH in human plasma.
Table 2. Effect of foreign substances on the RLS signal of TZH and
CPH (18 ng/mL)
Foreign substances

Tolerance limit
(Foreign substance to analyte ratio)
TZH

CPH

DL-Aspartic acid

300

300

Alanine

250

300

L-Isoleucine

250

150

L-Tyrosine

500

150

Glycine

700

600

Glucose

700

600

Lactose

1000

600

Saccharose

1000

900

K+

1000

2000

Cl -

1000

2000

+

Li

1000

1000

SO42-

1000

1000

2+

50

25

2+

100

50

Zn 2+

100

50

2+

250

250

Fe3+

250

250

Mg
Ca
Ba

NO3

-

Na+
CO32-

250

250

1000

500

500

300
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Table 3. Results of the determination of TZH and CPH in pharmaceutical preparations
Nominal Content (mg/sample)

Founda (mg/sample)

Recovery (%)

Thioridazine HCl Tablet

10

10.1 ± 0.3

101.3

Chlorpromazine HCl Tablet

25

25.0 ± 0.4

100.1

Chlorpromazine HCl Injection

50

49.9 ± 0.5

99.8

Amount Added (ng/mL)a

Amount Found (ng/mL)b

Recovery (%)

Sample

a

Average of three determinations ± SD.

Table 4. Recoveries of drugs added to pharmaceutical formulations and human plasma
Sample

Analyte

Thioridazine HCl Tablets

Chlorpromazine HCl Tablets

Chlorpromazine HCl Injections

Human Plasma

c

TZH

3.0

3.0 ± 0.2

99 ± 7

6.0

6.1 ± 0.3

102 ± 5

10.0

10.5 ± 0.5

105 ± 5

3.0

2.9 ± 0.1

97 ± 3

CPH

6.0

6.1 ± 0.3

102 ± 5

10.0

10.3 ± 0.4

103 ± 4

3.0

2.9 ± 0.2

96 ± 7

CPH

6.0

6.0 ± 0.2

100 ± 3

10.0

10.1 ± 0.3

101 ± 3

0.5

0.5 ± 0.0

100 ± 6

1.0

1.0 ± 0.1

104 ± 12

2.0

2.0 ± 0.2

99 ± 7

0.5

0.5 ± 0.0

102 ± 6

1.0

1.0 ± 0.1

104 ± 6

2.0

2.1 ± 0.2

103 ± 12

TZH

CPH

a

The given values are concentrations in final solution.
Average of five determinations ± SD.
c
The added and found values for human plasma are in µg/mL in initial plasma samples.
b

Table 5. Comparison of analytical characteristics of the proposed method with those of some previously published methods
Method
Spectrophotometry

Analyte

Linear range (µg/mL)

Limit of detection (ng/mL)

Reference

CPH

2-8

–

25

TZH

2 - 18

–

25

Voltammetry

CPH

0.05 - 1.20

Voltammetry

TZH

0.2 - 40.7

Chemiluminescence

47

26

20.3

27
28

CPH

0.002 - 1.000

0.4

TZH

0.005 - 1.000

0.7

Fluorimetry

TZH

0.015 - 2.000

5.5

30

HPLC

CPH

0.01 - 1.00

0.27

32

HPLC
Nanogold-based RLS

TZH

0.1 - 10.0

2.7

CPH

0.07 - 10.00

30.6

TZH

0.07 - 10.00

21.4

CPH

0.0035 - 0.0300

1.0

TZH

0.0036 - 0.0360

1.1

CONCLUSIONS
In this work resonance light scattering spectroscopy was
successfully applied to determine two phenothiazine drugs

35
This work

using analyte-mediated aggregation of GNPs. Through the
electrostatic interaction with cationic TZH or CPH molecules and also covalent binding with their S atoms, GNPs
can aggregate to form a network structure, which results in

416
Journal of Food and Drug Analysis, Vol. 19, No. 4, 2011

greatly enhanced RLS. The proposed method is sensitive
and convenient and can be accomplished with a common
spectrofluorimeter. The accuracy, precision and selectivity
of the method is proved to be satisfactory and based on these
considerations, the proposed method can be used for analysis
of pharmaceutical formulations and biological samples.
Comparison of analytical features of this method with
those of some previously reported methods (Table 5) indicates that LOD of the developed method are better than or
comparable with most of the other methods. Also compared
to chromatographic methods, our method is simpler and less
time-consuming.
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